Rapid Micro Biosystems (RPID) Non-Current Debt (2020 - 2026)

Name: Rapid Micro Biosystems (RPID) Non-Current Debt (2020 - 2026) | Business Quant
Creator: Business Quant

Rapid Micro Biosystems recorded quarterly Non-Current Debt of $19.1 million in Q1 2026, up 0.8% quarter-over-quarter from $18.9 million in Q4 2025.

Rapid Micro Biosystems' Non-Current Debt history runs 4 years deep, the most recent figure standing at $19.1 million for Q1 2026.

In Q1 2026, Non-Current Debt changed N/A year-over-year to $19.1 million; the TTM figure through Mar 2026 stood at $19.1 million (changed N/A YoY), while the FY2025 annual figure was $18.9 million, changed N/A from the prior year.
Non-Current Debt came in at $19.1 million for Q1 2026 at Rapid Micro Biosystems, up from $18.9 million in the prior quarter.
In the past five years, Non-Current Debt ranged from a high of $19.1 million in Q1 2026 to a low of $18.8 million in Q3 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	29.64 Bn
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	14.22 Bn
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	27.88 Bn
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	10.99 Bn
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	598.50 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	8.07 Bn
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	10.13 Bn
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	1.81 Bn
10	Rapid Micro Biosystems	89.50 Mn	66.56 Mn	371,000.00	19.05 Mn

Download Data 🔒